Skip to content

Clinical trials

Phase 1/2 Squamous Cell Carcinoma of Head and Neck trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 1/2 Country / region: South Korea Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20161
20181
20193
20201
20214
20222
20233
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11
Active, not recruiting5
Completed4
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Alentis Therapeutics AG1
AstraZeneca1
BicycleTx Limited1
CJ Bioscience, Inc.1
Cellid Co., Ltd.1
Eisai Inc.1
GI Innovation, Inc.1
Genmab1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck24
Carcinoma, Non-Small-Cell Lung13
Melanoma7
Stomach Neoplasms7
Carcinoma, Renal Cell6
Colorectal Neoplasms6
Uterine Cervical Neoplasms6
Neoplasm Metastasis5
Head and Neck Neoplasms4
Triple Negative Breast Neoplasms4

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.